dc.contributor.author | Soylu, S | |
dc.contributor.author | Tas, M | |
dc.contributor.author | Bati, H | |
dc.contributor.author | Caliskan, N | |
dc.date.accessioned | 2020-06-21T15:36:56Z | |
dc.date.available | 2020-06-21T15:36:56Z | |
dc.date.issued | 2005 | |
dc.identifier.issn | 0108-2701 | |
dc.identifier.uri | https://doi.org/10.1107/S0108270105009868 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/21098 | |
dc.description | SOYLU, SERKAN M/0000-0002-8440-1260; TAS, MURAT/0000-0002-2879-6501 | en_US |
dc.description | WOS: 000228915400039 | en_US |
dc.description | PubMed: 15876732 | en_US |
dc.description.abstract | In the title compound, C14H11BrN2O2, which has the oxime group in an E conformation, molecules are linked by strong O-H••• O and N-H••• O hydrogen bonds into chains of edge-fused rings, unlike closely related compounds. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Blackwell Munksgaard | en_US |
dc.relation.isversionof | 10.1107/S0108270105009868 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | N-1-(4-bromophenyl)-N-2-hydroxy2-oxo-2-phenylacetamidine | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 61 | en_US |
dc.identifier.startpage | O343 | en_US |
dc.identifier.endpage | O344 | en_US |
dc.relation.journal | Acta Crystallographica Section C-Crystal Structure Communications | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |